The new research centre will be separate from the joint Tampere University and state-owned vaccine research company, which consists of Tampere University’s well-known Vaccine Research Center and Finnish Institute for Health and Welfare’s (THL) commercial vaccine research operations. The vaccine research company is a so-called special-assignment company steered by the Ministry of Social Affairs and Health.
VACCIM and the vaccine research company complement each other's expertise: VACCIM is MET’s research centre that concentrates on academic scientific research whereas the vaccine research company carries out clinical phase 1–4 vaccine trials in collaboration with pharmaceutical companies.
Enquiries:
Professor of Virology Heikki Hyöty, heikki.hyoty [at] tuni.fi (heikki[dot]hyoty[at]tuni[dot]fi)
Professor of Pharmacology Eeva Moilanen, eeva.moilanen [at] tuni.fi (eeva[dot]moilanen[at]tuni[dot]fi)